itraconazole has been researched along with Immunoproliferative Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawakami, J; Mino, Y; Naito, T; Watanabe, T; Yagi, T; Yamada, H; Yamada, T | 1 |
1 other study(ies) available for itraconazole and Immunoproliferative Disorders
| Article | Year |
|---|---|
Hydroxy-itraconazole pharmacokinetics is similar to that of itraconazole in immunocompromised patients receiving oral solution of itraconazole.
Topics: Administration, Oral; Aged; Antifungal Agents; Chromatography, Liquid; Drug Administration Schedule; Female; Glomerular Filtration Rate; Hematologic Neoplasms; Humans; Immunocompromised Host; Immunoproliferative Disorders; Itraconazole; Male; Middle Aged; Mycoses; Serum Albumin; Solutions; Tandem Mass Spectrometry | 2013 |